Skip to main content

Guidance and regulation

Skip to results
205 results sorted by Most viewed
From Veterinary Medicines Directorate (VMD)
  • Marketing Authorisations Veterinary Information Service (MAVIS) edition 107

  • Marketing Authorisations Information Service (MAVIS) Hub edition 123.

  • Cat owner concerns: flea and tick spot-on products

  • Action following notification of suspension or expiry of an authorisation to market an animal medicine if it fails to comply with the regulations.

  • Marketing Authorisations Information Service (MAVIS) Hub edition 113

  • News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).

  • Marketing Authorisations Information Service (MAVIS) Hub edition 121.

  • Marketing Authorisations Veterinary Information Service (MAVIS) edition 103

  • These documents describe LA-MRSA (Livestock associated Meticillin resistant Staphylococcus aureus) and the steps you can take to reduce the chance of infection.

  • Explanation for animal owners and veterinary health professionals on how the VMD calculates adverse event incidence rates for veterinary medicines

  • Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 133.

  • Marketing Authorisations Veterinary Information Service (MAVIS) edition 104

  • Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 110.

  • Details of the VMD Corporate Priorities for 2024 - 2025.

  • Marketing Authorisations Information Service (MAVIS) Hub edition 129

  • Marketing Authorisations Veterinary Information Service (MAVIS) edition 108

  • Marketing Authorisations Information Service (MAVIS) Hub edition 116

  • Marketing Authorisations Information Service (MAVIS) Hub edition 125.

  • Marketing Authorisations Information Service (MAVIS) Hub edition 126.

  • VMD Published Standards for regulatory work 2022-2023.